MedPath

Clinical Performance Evaluation of DxN HBV Assay

Terminated
Conditions
Hepatitis B
Interventions
Diagnostic Test: DxN HBV Assay
Registration Number
NCT03123159
Lead Sponsor
Beckman Coulter, Inc.
Brief Summary

The DxN Hepatitis B Virus (HBV) Assay is an in vitro diagnostic assay intended as an aid in the management of HBV-infected individuals undergoing antiviral therapy. The purpose of the study is to establish the clinical performance of the DxN HBV Assay for plasma samples in the intended use population.

Detailed Description

Same as brief summary.

Recruitment & Eligibility

Status
TERMINATED
Sex
All
Target Recruitment
60
Inclusion Criteria
  • Subject is 18 years of age or older
  • Subject has serological evidence of chronic HBV infection, and measurable HBV-DNA and ALT at baseline
  • Subject will undergo treatment with tenofovir or entecavir for a minimum of 48 weeks
Exclusion Criteria
  • Co-infection with HIV or HCV at enrollment
  • Subject has decompensated liver disease or liver cancer
  • Prior participation in study
  • Current or planned participation in an investigational drug or device study

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Arm && Interventions
GroupInterventionDescription
HBV Infected patientsDxN HBV Assaychronic HBV patients who will undergo standard of care FDA approved antiviral therapy to treat HBV infections. Will have blood drawn to be tested using the DxN HBV Assay. Study is observational and results will not be used to manage patient care.
Primary Outcome Measures
NameTimeMethod
Sustained Virologic Response (SVR)Up to 48 weeks

Defined as unquantifiable HBV Viral load at 48 weeks of treatment.

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (10)

Scripps Clinic

๐Ÿ‡บ๐Ÿ‡ธ

La Jolla, California, United States

University of Minnesota Medical School

๐Ÿ‡บ๐Ÿ‡ธ

Minneapolis, Minnesota, United States

Weill Cornell Medical College

๐Ÿ‡บ๐Ÿ‡ธ

New York, New York, United States

St. Luke's Lipid and Diabetes Research Center

๐Ÿ‡บ๐Ÿ‡ธ

Kansas City, Missouri, United States

Baylor College of Medicine

๐Ÿ‡บ๐Ÿ‡ธ

Houston, Texas, United States

Centre Hospitalier de l'universite de Montreal

๐Ÿ‡จ๐Ÿ‡ฆ

Montreal, Quebec, Canada

University of Washington / Harborview Medical Center

๐Ÿ‡บ๐Ÿ‡ธ

Seattle, Washington, United States

University of Mississippi Medical Center

๐Ÿ‡บ๐Ÿ‡ธ

Jackson, Mississippi, United States

Albert Einstein Medical School

๐Ÿ‡บ๐Ÿ‡ธ

Philadelphia, Pennsylvania, United States

University Health Network

๐Ÿ‡จ๐Ÿ‡ฆ

Toronto, Ontario, Canada

ยฉ Copyright 2025. All Rights Reserved by MedPath